• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Cleveland HeartLab LLC

Cleveland HeartLab pulls in $15M | Wall Street Beat

November 1, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Cleveland HeartLab pulled in $14.7 million in equity financing for its proprietary test for cardiac inflammation, according to a regulatory filing.

The CardioMPO test was developed by Dr. Stanley Hazen, director of the Cleveland Clinic’s center for cardiovascular diagnostics and prevention.

Cleveland HeartLab closed a $3 million round in 2010, with backers including Glengary and Second Generation Ltd.

Filed Under: Funding Roundup, News Well, Wall Street Beat Tagged With: 480 Biomedical, Arsenal Medical, Carestream Health Inc., Cleveland HeartLab LLC, conformis, Genesis Digital Imaging, LeMaitre Vascular Inc., neovasc, Oculeve

Bupp steps down as Neoprobe CEO | Personnel moves

April 1, 2011 By MassDevice staff Leave a Comment

MassDevice.com Personnel Moves

Neoprobe Corp. (NYSE Amex:NEOP) is getting a new chief executive and, perhaps, a new board member.

The Dublin, Ohio-based cancer diagnostics firm announced that CEO David Bupp will be replaced by chief development officer Mark Pykett on April 15.

Filed Under: News Well Tagged With: Alphatec, Cleveland HeartLab LLC, Delcath Systems Inc., Golden Meditech Holdings Ltd., LipoScience Inc., Magnetecs Corp., Minnetronix Medical, Navidea Biopharmaceuticals, Novella Clinical Inc., Personnel Moves, Zoll Medical

Cardiac biomarker gets second life

March 18, 2010 By MedCity News Leave a Comment

MedCity News logo

By Mary Vanac

Jake Orville always thought the cardiac inflammation biomarker developed by Dr. Stanley Hazen and his colleagues at the Cleveland Clinic was a valuable and proven technology. But his efforts to make it a commercial success for spinoff company PrognostiX failed, largely due to the difficulty of getting the test through clinical trial process required by the Food & Drug Administration.

Filed Under: Business/Financial News, Diagnostics, News Well Tagged With: Cleveland HeartLab LLC

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS